Interestingly, patients with SCN5A cardiac channelopathies have an increased prevalence of irritable bowel syndrome (IBS) [3], and conversely, functionally abnormal SCN5A mutations are present in 2–3% of IBS patients [4–6]. This evidence concerns the gene SCN5A and irritable bowel syndrome.